🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Alkermes plc

ALKS Healthcare
$36.95 $-0.03 (-0.08%)
Market Cap: $6.16 B
Gurus Holding
9
Popularity Rank
#559
% of Shares Held
4.38%
Net Activity (Q1 2026)
-$31.93 M

Guru Ownership Trend

Guru Analysis for Alkermes plc (ALKS)

Alkermes plc (ALKS), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q1 2026, a total of 9 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $269.85 M.

Top institutional holders include Renaissance Technologies (RenTech) and Ken Fisher.

Institutional sentiment is currently Slightly Bearish. This is evidenced by a $31.93 M net outflow during the quarter.

Recent activity highlights Louis Moore Bacon who opened a new position. Conversely, Ray Dalio reduced exposure by 75.7%.

Key Holders

Top 5 by Value

Recent Activity Breakdown (Q1 2026)

+$5.88 M
Total Buy Value
New Buys 1
Additions 1
-$37.8 M
Total Sell Value
Reductions 6
Sold Out 2

Guru Consensus (Q1 2026)

Based on recent activity
Net Sellers
8
Net Buyers
2

FAQs for Alkermes plc (ALKS)

Major holders include Renaissance Technologies (RenTech) ($217.83 M), Ken Fisher ($13.81 M), Cliff Asness ($13.58 M). According to the latest reported data, 9 tracked investment managers collectively hold approximately 7.3 M shares.

According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $31.93 M, with 2 managers increasing positions and 8 managers reducing holdings.

During the most recent reporting period, 6 managers trimmed their positions, while 2 fully exited ALKS. The total reported sell value was $37.8 M.

Yes, 1 managers opened new positions in ALKS, and 1 increased their existing holdings. The total reported buy value was $5.88 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.34% Reduce -7.6% 6,160,428 $217.83 M Q1 2026
0.00% Reduce 0.0% 390,479 $13.81 M Q1 2026
0.01% Reduce -25.3% 383,977 $13.58 M Q1 2026
0.11% New Buy 158,499 $5.6 M Q1 2026
0.01% Reduce -75.7% 83,806 $2.96 M Q1 2026
0.02% Add 16.0% 55,683 $1.97 M Q1 2026
0.00% Reduce -33.5% 41,548 $1.47 M Q1 2026
0.01% Reduce -4.4% 21,099 $746,061 Q1 2026
0.04% 7,652 $270,575 Q1 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form